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Avaliação in vitro do potencial antiviral de Guettarda angelica 
contra herpesvírus animais
In Vitro Evaluation of the Antiviral Potential of Guettarda angelica Against Animal Herpesviruses 
Alyne Vieira Barros1,3, Lorena Mendes Araújo2, Fernando Faustino de Oliveira2, Aline Oliveira da Conceição2, 
Isabela Cristina Simoni1, Maria Judite Bittencourt Fernandes1 & Clarice Weis Arns1,3
ABSTRACT
Background: The number of antiviral studies using plant extracts has increased in the last decades, and the results have 
shown that plants are potential sources of compounds that are able to inhibit and/or decrease viral infections. The selec-
tion of these plants by ethnopharmacological criteria increases the probability of fi nding new substances with signifi cant 
pharmacological and biological activities. Hence, Brazil has an advantage in this area due to its extensive biodiversity and 
ethnological diversity. Guettarda angelica is a plant from the Brazilian Caatinga region the roots of which are popularly 
used for various therapeutic purposes, including veterinary use. The aim of this work was to investigate the in vitro antiviral 
activity of extracts of plant parts from G. angelica against three animal herpesviruses: bovine (BoHV-1), suid (SuHV-1) 
and equine (EHV-1) herpesviruses type 1.
Materials, Methods & Results: The extracts of roots, leaves and seeds of G. angelica were initially screened for in vitro 
antiviral activity against these herpesviruses using the virus yield reduction assay. The MDBK cells were used in assays 
with BoHV-1 and SuHV-1, and the Vero cells with EHV-1. For these assays, the cells previously treated with the extracts 
in non-cytotoxic concentrations were inoculated with logarithmic dilutions of each virus. The viral inhibitory activity 
of extracts was calculated by difference of virus titer between treated infected cells and non-treated infected cells. Only 
the aqueous extract from seeds (AEs) showed a signifi cant antiviral activity (P < 0.01, ANOVA followed by Tukey test) 
against all herpesviruses leading continuous studies. Thus, the selectivity index (SI) of this extract was determined by 





. The 50% cytotoxic concentration (CC
50
) was defi ned as the extract concentration that reduced the cell viability by 
50% when compared to untreated controls; the 50% inhibitory concentration (IC
50
) was defi ned as the concentration of the 




 were obtained from 
nonlinear regression analysis of concentration-effect curves by the GraphPad Prism 5 Demo program and represented the 
means ± standard deviation of three independent experiments. The CC
50
 for Vero cells was 400.60 ± 0.20 µg/mL, while 
the CC
50
 for MDBK cells was 920.50 ± 0.19 µg/mL. The IC
50
 values of the AEs on the BoHV-1, SuHV-1 and EHV-1 were 
22.79 µg/mL, 91.30 µg/mL and 19.95 µg/mL, respectively. The SI values of this extract for each virus obtained from these 
data were 40.39, 10.08 and 20.08 for BoHV-1, SuHV-1, and EHV-1, respectively.
Discussion: To ensure the antiviral activity of a plant extract and consequently its  future use as antiviral agent is crucial the 
obtainment of its selectivity index or safety index. It is guarantee of a true antiviral effect and not the result of cytotoxicity 
of the extract on cells, and that could be confused with an antiviral activity. Other important point  are the extract IC
50
 values 
less than 100 µg/mL. The results of the AEs of G. angelica are in accordance with these considerations indicating that the 
G. angelica seeds may be a potential source of antiviral compounds insurance and encouraging further investigation of them.
Keywords: Guettarda angelica, bovine herpesvirus type 1, suid herpesvirus type 1, equine herpesvirus type 1, antiviral 
activity.
Descritores: Guettarda angelica, herpesvírus bovino tipo 1, herpesvírus suíno tipo 1, herpesvírus equino tipo 1, atividade 
antiviral.
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INTRODUCTION
Herpesviruses are responsible for important 
diseases in almost all domestic animal species. Bovine 
herpesvirus 1 (BoHV-1) is the major pathogen of cattle, 
responsible for various clinical manifestations  includ-
ing the infectious bovine rhinotracheitis (IBR) and re-
productive disorders. The suid herpesvirus 1 (SuHV-1) 
causes a disease in pigs known as Aujeszky’s disease 
where the economic impact on the pig industry world-
wide is due to the high rates of morbidity and mortal-
ity leading to restrictions on the international trade of 
swine products. Equine herpesvirus 1 (EHV-1) is an 
important ubiquitous enzootic equine pathogen [22].
Despite advances in medical strategies to control 
viral infections have taken place, the viruses are still a 
cause of concern and represent a risk for public health. The 
search for antiviral drugs more effective and affordable 
is one of strategies to control the viral infections[8,9,20]. 
Plants and their derivatives may serve as promising 
sources of novel antiviral compounds [6,10,18,20,25].
Guettarda angelica, is a plant found in the 
“Caatinga” region of northeastern Brazil with a broad 
medicinal use of its roots including in veterinary area. 
In our previous studies, extracts from G. angelica root 
showed in vitro antibacterial activity [2].
The number of antiviral studies with plant 
extracts has increased in the last decades, and the re-
sults have shown that plants are potential sources of 
compounds that are able to inhibit and/or decrease viral 
infections [6,10,18,20]. Therefore, the aim of this study 
was to evaluate the in vitro antiviral activity of G. an-
gelica extracts against these three animal herpesviruses.
MATERIALS AND METHODS
Plant material
The root barks, leaves and seeds of Guettarda 
angelica Mart. ex Müll. Arg. (Rubiaceae) were col-
lected at a small beach in Lomanto, in the region of 
Jequié (13° 51’ S, 40° 14’ W), Bahia State, Brazil, in 
December, 2003. A voucher specimen was deposited 
in Herbarium of the Centro de Pesquisa do Cacau (BA) 
and identifi ed as NY Specimen ID 1015301. 
Preparation of extracts
The crude aqueous extracts from seeds (AEs) 
and leaves (AEl) were prepared by grinding the dried 
materials in a mixer, followed by the addition of dis-
tilled water (10%, w/v) and incubation at 4°C for 8 h 
(AEs) or 24 h (AEl). To prepare the aqueous extract 
from the root barks (AEr), the material was boiled for 
15 min. All aqueous extracts were fi ltered through fi lter 
paper and freeze-dried. The methanolic extract from 
the root barks (MeOHEr) was also prepared and subse-
quently partitioned with organic solvents to obtain the 
hexane (HexF), ethyl acetate (AcOEtF) and aqueous 
(AqF) fractions. Briefl y, 5 g of powdered root bark was 
initially soaked in 50 mL of methanol for 24 h and then 
soaked again for another 24 h. The resultant extract was 
fi ltered and concentrated in a rotary evaporator under 
reduced pressure at a temperature of 30°C. Organic 
extracts were solubilized in a 45% solution of dimethyl 
sulfoxide (DMSO)1 and freeze-dried.
All freeze-dried fractions and extracts were 
solubilized in equal parts of distilled water and Earle 
minimum essential medium (MEM)2 twice concen-
trated to reach a fi nal concentration of 5,000 µg/
mL, except for the EAr (4,000 µg/mL). The samples 
were then sterilized by fi ltration (0.22 µm fi lter) and 
stored at -20ºC.
Viruses and cell lines
The Los Angeles strain of BoHV-1 and Nova 
Prata strain of SuHV-1 were propagated in Madin 
Darby bovine kidney cells - MDBK (ATCC-CCL 22). 
The A4/72 strain of EHV-1 was propagated in African 
green monkey kidney cells - Vero (ATCC-CL 81). The 
MDBK and Vero cells were maintained in MEM with 
10% fetal calf serum. To perform the tests, the cells 
were seeded in 96-well sterile microplates at 3x104 




Determination of cytotoxicity by cell morphology analysis
After 24 h of cell seeding, the medium was 
removed, and the cells were exposed to 100 µL of 
increasing concentrations of plant fractions and ex-
tracts, ranging from 5.0 to 2,500 µg/mL, except for 
AEr (4.0 to 2,000 µg/mL), in triplicate. The controls 
consisted of cells incubated with MEM only. To 
determine the maximum non-cytotoxic concentra-
tion (MNCC), the cell morphology alterations were 
observed until 96 h after the treatment by inverted 
light microscopy.
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Determination of antiviral effect
Antiviral screening was based on the viral 
yield reduction technique [9]. Briefly, 24 h after 
cell seeding and withdrawal of the medium, the 
cells were treated with 100 µL of extracts or frac-
tions at dilutions corresponding to each MNCC. 
After 1 h of incubation, 50 µL of logarithmic dilu-
tions of each virus were added, in triplicate, and 
the microplates were incubated again. The controls 
consisted of untreated infected cells (virus titer), 
untreated non-infected cells (cell control) and the 
positive antiviral control (Acyclovir - SQRFB)3. 
The cells were observed for the presence of the 
cytopathic effect (CPE) every day for up to 4-6 days 
after treatment. The viral titers were determined by 
the 50% infective dose in tissue culture (TCID
50
), 
and the antiviral activity was determined by the dif-
ference of the viral titers between treated-infected 
cells and untreated-infected cells and expressed 
as viral inhibition index (VII). A plant extract was 
considered an inhibitor when the VII was  1.5 
[26]. ANOVA followed by Tukey test was used to 
evaluate the difference between the VII values. A 
P value of less 0.01 was considered statistically 
significant. The inhibitor extracts were further 
assessed by the MTT4 (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide-Sigma) 
colorimetric method.
 MTT colorimetric assay
Both cell viability and antiviral activity 
were evaluated by the MTT technique as described 
elsewhere [30] with minor modifications. For the 
cell viability assay, after 24 h of cell seeding and 
withdrawal of the medium, the cells were incubat-
ed with 100 µL/well of increasing concentrations 
of plant extracts in quadruplicate. After 48-72 
h, the medium was removed, and 50 µL of MTT 
solution (1 mg/mL, Sigma) prepared in MEM was 
added to each well. After 4 h of incubation, the 
MTT solution was removed, and 100 µL of sodium 
dodecyl sulfate1 in 10% 0.001 N HCl was added 
to dissolve formazan crystals. The microplates 
were incubated overnight, and the intensity of the 
color (absorbance) was automatically measured 
using the spectrophotometer (Spectra Max Plus 
384) and a wavelength of 540 nm. The controls 
consisted of cells incubated with MEM only. The 
50% cytotoxic concentration (CC
50
) was defined 
as the material concentration that reduced the 
cell viability by 50% when compared to untreated 
controls.
This same procedure was used to obtain 
the minimal concentration of extracts required to 
inhibit 50% of viral growth, except for the addition 
of viral suspension containing 200 TCID/100 µL 
after adding the extract dilutions. The viral controls 
consisted of the cells incubated with MEM and 
virus. The 50% inhibitory concentration (IC
50
) was 
defined as the concentration of the material that 
inhibited 50% of viral replication when compared 





were obtained from nonlin-
ear regression analysis of concentration-effect curves 
by the GraphPad Prism 5 Demo program and represent 
the means ± standard deviation of three independent 
experiments. The selectivity index (SI) was calculated 






The maximum non-cytotoxic concentrations 
(MNCCs) of the each plant extract and fraction 
from G. angelica are shown in Table 1. In MDBK 
cells, the MNCCs for aqueous extracts from the 
leaves (AEl), seeds (AEs) and roots (AEr) were 
800 µg/mL, 400 µg/mL and 250 µg/mL, respec-
tively; in addition, the MNCC for the methanolic 
extract from roots (MeOHEr) was 200 µg/mL. In 
Vero cells, these values were 1,250 µg/mL (AEl), 
625 µg/mL (AEs), 500 µg/mL (AEr) and 312 µg/
mL (MeOHEr). The MeOHEr fractions AqF and 
AcOEtF showed the highest values of MNCC and 
were equal for both cells, corresponding to a low 
cytotoxicity (1,600 µg/mL for MDBK cells and 
1,250 µg/mL for Vero cells). On the other hand, 
the HexF fraction demonstrated higher cytotoxic-
ity, with a MNCC of 80 µg/mL (Vero cells) and 
50 µg/mL (MDBK cells).
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Table 1. Cytotoxicity of Guettarda angelica extracts and fractions and their antiviral activities against bovine (BoHV-1), 
suid (SuHV-1) and equine (EHV-1) herpesviruses 1.
Extracts
MNCC (µg/mL) VII*
Vero Cells MDBK Cells BoHV-1 SuHV-1 EHV-1
AEr 500 250 0.57 0.11 0.69
MeOHEr 312 200 0 0.62 0.60
AqF 1,250 1,600 0.50 0.50 0.50
AcOEtF 1,250 1,600 1.13 0 0.56
HexF 80 50 0 0 0.13
AEl 1,250 800 0.63 0.24 1.13
AEs 625 400 2.30 2.72 1.57
AEr: aqueous extract from root barks; MeOHEr: ethanolic extract from root barks; AqF (aqueous), AcOEtF (ethyl acetate), 
and HexF (hexane) fractions from MeOHEr fractionation; AEl: aqueous extract from leaves; AEs: aqueous extract from seeds. 
MNCC: maximum non-cytotoxic concentration; VII: viral inhibition index; *P < 0.01 by Anova followed by Tukey test.
The antiviral screen of plant extracts and frac-
tions was carried out in MDBK cells infected with 
BoHV-1 and SuHV-1 and in Vero cells infected with 
EHV-1. As seen in Table 1, AEs showed antiviral activ-
ity against the three viruses, with VII of 2.30 (BoHV-1), 
2.72 (SuHV-1) and 1.57 (EHV-1). Unlike, the remain-
ing extracts and fractions reached a VII lower than 1.5 
and did not demonstrate an antiviral effect against any 
of the viruses. The three virus strains were resistant to 
acyclovir (data not shown).
As the AEs was the only extract to present 
signifi cant antiviral activity in the screening assays, it 
was evaluated by the MTT assay (Table 2). The CC
50
 
for Vero cells was 400.60±0.20 µg/mL, while the CC
50 
for MDBK cells was 920.50 ± 0.19 µg/mL. The IC
50 
values of the AEs on the BoHV-1, SuHV-1 and EHV-
1 were 22.79 µg/mL, 91.30 µg/mL and 19.95 µg/mL, 
respectively. The SI values of this extract for each virus 
obtained from these data were 40.39, 10.08 and 20.08 
for BoHV-1, SuHV-1, and EHV-1, respectively.
Table 2. Selectivity index (SI) and cytotoxic and antiviral activities of the aqueous extract from Guettarda angelica seeds (AEs) against bovine (BoHV-
1), suid (SuHV-1) and equine (EHV-1) herpesviruses 1 by the MTT assay.
Extract










AEs 400.60 ± 0.20 920.50 ± 0.19 22.79 ± 0.04 40.39 91.30 ± 0.03 10.08 19.95 ± 0.01 20.08






The initial strategy of the present work 
was based on an ethnopharmacology approach to 
G. angelica. The medicinal use of its roots includes the 
treatment of anemia, dyspepsia, pains and fever, and 
in veterinary medicine, it is used against fever and to 
“cure” bovine and equine diarrhoea [1,5]. In our pre-
vious studies, methanolic and aqueous extracts from 
G. angelica root bark showed in vitro antibacterial 
activity against Gram-positive bacteria [5]. This work 
focused on the antiviral activity of different parts of 
this plant against the animal herpesviruses.
In a study using the roots from another spe-
cies of Guettarda, G. platypoda demonstrated an 
antiviral activity against the vesicular stomatitis virus 
and rhinovirus [2]. Other studies reported the antiviral 
activity of roots or stem barks of other Brazilian plants 
against the BoHV-1 [13] and SuHV-1 [16,21]. Despite 
these reports, in our initial studies using the viral 
yield reduction assay, neither root nor leaf extracts of 
G. angelica presented antiviral activity against the three 
animal herpesviruses. Although, several leaf extracts 
from other plant families showed promissory antivi-
ral results against the bovine and suid herpesviruses 
[12,16,17,21,26].
Otherwise, the seed extracts demonstrated 
antiviral activity against these viruses. This assay as 
well as other techniques, such as plaque reduction/
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inhibition assay [9,13], inhibition of virus-induced cy-
topathic effect [9,24] and endpoint titration technique 
[4,9] have been used for the in vitro determination 
of antiviral activity of plant extracts or compounds. 
The ACV was used as a positive control in this assay. 
However, all herpesvirus strains showed resistance 
to this drug. Previous reports have described both 
resistance and susceptibility of BoHV-1 and SuHV-1 
to this antiviral [11,28]. Another study [14] reported 
a moderate effect of ACV against EHV-1 in vitro 
and the ACV has been used on a limited basis in 
veterinary medicine. Mutant viruses resistant to the 
existing antiviral agents always arise upon treatment 
(9,25). Furthermore, the synthetic antiviral drugs that 
are available in the market are often expensive and 
unsatisfactory, with restricted targets and potential 
adverse effects [8,9,20]. In this context, research on 
antiviral compounds of plant origin that are effective 
against ACV-resistant viral strains is worth pursuing.
The preliminary results obtained with the seeds 
of G. angelica were promising and motivated us to con-
tinue this study. Herein, AEs was also evaluated by the 
MTT method to obtain its SI. The SI is fundamental to 
determine any possible toxic effect of the extract on the 
cells that could be confused with an antiviral activity. 
According with the SI value, it can be concluded that 
the antiviral activity of a plant extract is real and not a 
result of its cytotoxic effect on cells. Therefore, the SI 
verifi es the safety index of the material tested. More-
over, an antiviral activity is relevant when the extract 
tested has IC
50
 values below 100 µg/mL [9]. Taken 
together, the IC
50
 and SI values of the AEs extract are 
in accordance with this conclusion. In another studied 
carried out by our research group [3] the mechanism 
of antiviral action of AEs extract against the BoHV-1 
and SuHV-1 was also investigated. In this study, this 
plant extract inhibited the viral replication of the two 
viruses during and after the viral penetration, being 
only BoHV-1 inhibited by the AEs in the pretreatment. 
Moreover, AEs had a virucidal effect on both viruses. 
Thus, these results revealed an intra and extracellular 
effect of AEs.
The antiviral activity of the seeds from 
G. angelica could be attributed to the presence in the 
extract of compounds, such as proteins, peptides or 
fl avonoids, known for their antiviral properties [10,18]. 
Indeed, many studies have been published on the an-
tiviral activity from seed extracts against both human 
and other animal viruses [15,24,27,29]. Specifi cally 
about the viruses examined here, researches demon-
strated an antiviral activity of proteins extracted from 
seeds of Senna occidentalis against BoHV-1 [19] and 
a virucidal activity of a peptide isolated from Sorghum 
bicolor against diverse viruses, including BoHV-1 [7].
The inhibition of the three animal herpesvi-
ruses by an extract of the seeds of G. angelica encour-
ages further bioassay-guided fractionation to identify 
the compounds responsible for this antiviral effect. 
This is the fi rst description of an antiviral activity of 
G. angelica and its broad antiherpesviral spectrum, 
which makes it a promising source of antivirals.
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